These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36927431)

  • 1. Pan-cancer analysis confirms the prognostic and immunological effects of prostate tumor overexpressed-1 in human cancers.
    Liu F; Li Z; Wan S; Li Y; Ye Z; Li D
    Curr Cancer Drug Targets; 2023 Mar; ():. PubMed ID: 36927431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pan-cancer analysis to determine the prognostic analysis and immune infiltration of HSPA5.
    Zhu RK; Zhang W; Zhang YX; Hui Z; Wang XW
    Curr Cancer Drug Targets; 2023 May; ():. PubMed ID: 37157205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer.
    Lei F; Zhang L; Li X; Lin X; Wu S; Li F; Liu J
    BMC Cancer; 2014 Jun; 14():457. PubMed ID: 24947166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes.
    Yang Q; Lin H; Wu S; Lei F; Zhu X; Song L; Hong M; Guo L
    PLoS One; 2015; 10(8):e0136448. PubMed ID: 26305455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive pan-cancer analysis on the immunological role and prognostic value of
    Yang Y; Jiang L; Wang S; Chen H; Yi M; Wu Y; Li Z; Fang X
    Transl Cancer Res; 2022 Sep; 11(9):3187-3208. PubMed ID: 36237259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased PTOV1 expression is related to poor prognosis in epithelial ovarian cancer.
    Guo F; Feng L; Hu JL; Wang ML; Luo P; Zhong XM; Deng AM
    Tumour Biol; 2015 Jan; 36(1):453-8. PubMed ID: 25270739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of prostate tumor overexpressed 1 (PTOV1) is a potential prognostic biomarker for cervical cancer.
    Chen Y; Hu Z; Chai D
    Int J Clin Exp Pathol; 2017; 10(11):11044-11050. PubMed ID: 31966450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival.
    Chen SP; Zhang LS; Fu BS; Zeng XC; Yi HM; Jiang N
    Medicine (Baltimore); 2015 Jan; 94(4):e423. PubMed ID: 25634174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression.
    Alaña L; Sesé M; Cánovas V; Punyal Y; Fernández Y; Abasolo I; de Torres I; Ruiz C; Espinosa L; Bigas A; Y Cajal SR; Fernández PL; Serras F; Corominas M; Thomson TM; Paciucci R
    Mol Cancer; 2014 Mar; 13():74. PubMed ID: 24684754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
    Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits.
    Wu Z; Liu Z; Jiang X; Mi Z; Meng M; Wang H; Zhao J; Zheng B; Yuan Z
    J Exp Clin Cancer Res; 2019 Aug; 38(1):341. PubMed ID: 31387622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic pan-cancer analysis identifies RBM39 as an immunological and prognostic biomarker.
    Zhang R; Wang W; Zhang N; Chen X; Liu W; Zhang L; Liu N
    J Cell Mol Med; 2022 Sep; 26(18):4859-4871. PubMed ID: 35989423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpressed PTOV1 associates with tumorigenesis and progression of esophageal squamous cell carcinoma.
    Li R; Leng AM; Liu XM; Hu TZ; Zhang LF; Li M; Jiang XX; Zhou YW; Xu CX
    Tumour Biol; 2017 Jun; 39(6):1010428317705013. PubMed ID: 28651486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-Cancer Analysis Based on
    Zhang Y; Wang S; Han S; Feng Y
    Front Oncol; 2022; 12():844794. PubMed ID: 35359375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTOV1 facilitates colorectal cancer cell proliferation through activating AKT1 signaling pathway.
    Xie SA; Zhang W; Du F; Liu S; Ning TT; Zhang N; Zhang ST; Zhu ST
    Heliyon; 2024 Aug; 10(16):e36017. PubMed ID: 39229496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
    Liu P; Wang X; Pan L; Han B; He Z
    Front Immunol; 2022; 13():901784. PubMed ID: 35720327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells.
    Cánovas V; Puñal Y; Maggio V; Redondo E; Marín M; Mellado B; Olivan M; Lleonart M; Planas J; Morote J; Paciucci R
    Oncotarget; 2017 Aug; 8(35):59165-59180. PubMed ID: 28938627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of PTOV1 expression in cancers: A protocol for systematic review and meta-analysis.
    Yang Y; Li N; Tian G
    Medicine (Baltimore); 2021 Dec; 100(50):e28149. PubMed ID: 34918668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTOV1 is overexpressed in human high-grade malignant tumors.
    Fernández S; Mosquera JL; Alaña L; Sanchez-Pla A; Morote J; Ramón Y Cajal S; Reventós J; de Torres I; Paciucci R
    Virchows Arch; 2011 Mar; 458(3):323-30. PubMed ID: 21181414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.